Skincare range Epicutis invited the Aesthetics Journal to trial its line of products following its UK launch.
Based in the US, the brand has officially launched in the UK, and is on sale through aesthetic distributor Healthxchange. The skincare line features a range of products, including the Oil Cleanser, Lipid Serum and Arctigenin Brightening Treatment. Maxwell Stock, CEO and founder of Epicutis, told Aesthetics that his vision behind Epicutis was simplicity, offering a basic skincare routine with products featuring as few as eight ingredients.
Stock commented, “Epicutis is pioneering skincare with Arctigenin Brightening Treatment, a biotech breakthrough replacing unstable Vitamin C with Arctigenin – an advanced compound extracted from burdock seed. Clinically proven to transform skin in as little as 14 days, it delivers unmatched radiance, targeting pigmentation with precision. This is the future of scientifically driven, high-performance skincare.”
